Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
Edvan de Queiroz Crusoé; Flávia Cristina Fernandes Pimenta; Angelo Maiolino; Nelson Siqueira de Castro; Huiling Pei; Damila Trufelli; Mariana Fernandez; Luciana Barreto Herriot;
Hematol Transfus Cell Ther. 2021;43:417-23
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation ¿ a retrospective analysis
Russell Sterrett; Amarilis Figueiredo; Ranjeeta Mallick; Natasha Kekre; Harold Atkins; Arleigh McCurdy;
Hematol Transfus Cell Ther. 2021;43:437-42
Treatment of relapsed, refractory multiple myeloma: focus on new drugs
Angelo Maiolino;
Hematol Transfus Cell Ther. 2020;42 Supl 1:2-3